GemVax&KAEL Co.,Ltd engages in the manufacturing and commercializing of resins and filters for semi-conductor and panel display production in South Korea. The company offers impregnated active carbon and inorganic adsorbent coating resins; CA filter for removing chemical pollution substances and harmful gases in semiconductor and LCD/PDP manufacturing process; adsorbent towers for air pollution prevention; and pressure facility for preventing equipment erosion within a substation; and 5aver, a fire evacuation mask. It also engages in the research and development of anti-cancer immunotherapeutic and peptide drugs; and provides RIAVAX, an immunotherapeutic peptide for the treatment of locally advanced or metastatic pancreatic cancer. The company was founded in 1998 and is headquartered in Daejeon, South Korea.
| 14470 | |
| 13680 | |
| - | |
| 14740 | |
| 13420 | |
| 9060-23500 | |
| 561 074 M | |
| 35 672 K | |
| 78 886 M | |
| -206.2985 | |
| 1.3239 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
SEOUL, South Korea, March 30, 2021 /PRNewswire/ -- GemVax & KAEL Co., Ltd. (Korea: 082270) ("GemVax") has announced that a paper on GV1001, a novel Alzheimer's treatment based on telomerase modificati...
SEOUL, South Korea, March 30, 2021 /PRNewswire/ -- GemVax & KAEL Co., Ltd. (Korea: 082270) ("GemVax") has announced that a paper on GV1001, a novel Alzheimer's treatment based on telomerase modificati...
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
